Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong K, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker J-P, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan S-A, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes A-M, Arver B, Olsson H (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402–2416. https://doi.org/10.1001/jama.2017.7112

Article  CAS  PubMed  Google Scholar 

Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, t’veer LV, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. Jama 304:967–975. https://doi.org/10.1001/jama.2010.1237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. JNCI J National Cancer Inst 101:80–87. https://doi.org/10.1093/jnci/djn442

Article  CAS  Google Scholar 

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic

Buchanan AH, Voils CI, Schildkraut JM, Fine C, Horick NK, Marcom KP, Wiggins K, Skinner C (2017) Adherence to recommended risk management among unaffected women with a BRCA mutation. J Genet Couns 26:79–92. https://doi.org/10.1007/s10897-016-9981-6

Article  PubMed  Google Scholar 

Conley CC, Kasting ML, Augusto BM, Garcia JD, Cragun D, Gonzalez BD, Kim J, Ashing KT, Knott CL, Hughes-Halbert C, Pal T, Vadaparampil ST (2020) Impact of genetic testing on risk-management behavior of black breast cancer survivors: a longitudinal, observational study. Ann Surg Oncol 27:1659–1670. https://doi.org/10.1245/s10434-019-07982-9

Article  PubMed  Google Scholar 

Cragun D, Weidner A, Lewis C, Bonner D, Kim J, Vadaparampil ST, Pal T (2017) Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer 123:2497–2505. https://doi.org/10.1002/cncr.30621

Article  CAS  PubMed  Google Scholar 

Cragun D, Weidner A, Tezak A, Clouse K, Pal T (2020) Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers. Breast Cancer Res Tr 182:421–428. https://doi.org/10.1007/s10549-020-05699-y

Article  CAS  Google Scholar 

Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR (2007) Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clin Breast Cancer 7:875–882. https://doi.org/10.3816/cbc.2007.n.053

Article  PubMed  Google Scholar 

Garcia C, Wendt J, Lyon L, Jones J, Littell RD, Armstrong MA, Raine-Bennett T, Powell CB (2014) Risk management options elected by women after testing positive for a BRCA mutation. Gynecol Oncol 132:428–433. https://doi.org/10.1016/j.ygyno.2013.12.014

Article  PubMed  Google Scholar 

Robinson LS, Hendrix A, Xie X-J, Yan J, Pirzadeh-Miller S, Pritzlaff M, Read P, Pass S, Euhus D, Ross TS (2015) Prediction of cancer prevention: from mammogram screening to identification of BRCA1/2 mutation carriers in underserved populations. EBioMedicine 2:1827–1833. https://doi.org/10.1016/j.ebiom.2015.10.022

Article  PubMed  PubMed Central  Google Scholar 

Schwartz MD, Isaacs C, Graves KD, Poggi E, Peshkin BN, Gell C, Finch C, Kelly S, Taylor KL, Perley L (2012) Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancer 118:510–517. https://doi.org/10.1002/cncr.26294

Article  PubMed  Google Scholar 

Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B (2006) Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing. Cancer 107:2745–2751. https://doi.org/10.1002/cncr.22352

Article  CAS  PubMed  Google Scholar 

Custers JA, van den Berg SW, van Laarhoven HW, Bleiker EM, Gielissen MF, Prins JB (2014) The cancer worry scale. Cancer Nurs 37:E44–E50. https://doi.org/10.1097/NCC.0b013e3182813a17

Article  PubMed  Google Scholar 

Board CancerNE Hereditary Breast and Ovarian Cancer. In: Cancer.net. https://www.cancer.net/cancer-types/hereditary-breast-and-ovarian-cancer

Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, Armstrong K, Rebbeck TR, Domchek SM (2008) Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test 12:81–91. https://doi.org/10.1089/gte.2007.0037

Article  PubMed  PubMed Central  Google Scholar 

Julian-Reynier C, Eisinger F, Chabal F, Lasset C, Noguès C, Stoppa-Lyonnet D, Vennin P, Sobol H (2000) Disclosure to the family of breast/ovarian cancer genetic test results: patient’s willingness and associated factors. Am J Med Genet 94:13–18. https://doi.org/10.1002/1096-8628(20000904)94:1%3c13::aid-ajmg4%3e3.0.co;2-t

Article  CAS  PubMed  Google Scholar 

Kegelaers D, Merckx W, Odeurs P, Ende J, Blaumeiser B (2014) Disclosure pattern and follow-up after the molecular diagnosis of BRCA/CHEK2 mutations. J Genet Couns 23:254–261. https://doi.org/10.1007/s10897-013-9656-5

Article  CAS  PubMed  Google Scholar 

McGivern B, Everett J, Yager GG, Baumiller RC, Hafertepen A, Saal HM (2004) Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med 6:503–509. https://doi.org/10.1097/01.gim.0000144014.91237.a1

Article  CAS  PubMed  Google Scholar 

Montgomery SV, Barsevick AM, Egleston BL, Bingler R, Ruth K, Miller SM, Malick J, Cescon TP, Daly MB (2013) Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial. Fam Cancer 12:537–546. https://doi.org/10.1007/s10689-013-9609-z

Article  PubMed  PubMed Central  Google Scholar 

Conley CC, Ketcher D, Reblin M, Kasting ML, Cragun D, Kim J, Ashing KT, Knott CL, Hughes-Halbert C, Pal T, Vadaparampil ST (2020) The big reveal: family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer. J Genet Couns 29:410–422. https://doi.org/10.1002/jgc4.1196

Article  PubMed  PubMed Central  Google Scholar 

Dancyger C, Wiseman M, Jacobs C, Smith JA, Wallace M, Michie S (2011) Communicating BRCA1/2 genetic test results within the family: a qualitative analysis. Psychol Health 26:1018–1035. https://doi.org/10.1080/08870446.2010.525640

Article  PubMed  Google Scholar 

Daly MB, Montgomery S, Bingler R, Ruth K (2016) Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study. Fam Cancer 15:697–706. https://doi.org/10.1007/s10689-016-9889-1

Article  PubMed  PubMed Central  Google Scholar 

Patenaude AF, Dorval M, DiGianni LS, Schneider KA, Chittenden A, Garber JE (2006) Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 24:700–706. https://doi.org/10.1200/jco.2005.01.7541

Article  PubMed  Google Scholar 

Costalas JW, Itzen M, Malick J, Babb JS, Bove B, Godwin AK, Daly MB (2003) Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program’s experience. Am J Medical Genetics Part C Seminars Medical Genetics 119C:11–18. https://doi.org/10.1002/ajmg.c.10003

Article  Google Scholar 

Biskupiak J, Unni S, Telford C, Yoo M, Ye X, Deka R, Brixner D, Stenehjem D (2020) Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer. BMC Health Serv Res. https://doi.org/10.21203/rs.3.rs-43546/v1

Article  Google Scholar 

Metcalfe KA, Price MA, Mansfield C, Hallett DC, Lindeman GJ, Fairchild A, Posner J, Friedman S, Snyder C, Lynch HT, Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer (2020) Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis. Brit J Cancer 123:268–274. https://doi.org/10.1038/s41416-020-0861-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith AW, Dougall AL, Posluszny DM, Somers TJ, Rubinstein WS, Baum A (2008) Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psycho Oncol 17:767–773. https://doi.org/10.1002/pon.1291

Article  Google Scholar 

Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C (2002) Impact of BRCA1 / BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 20:514–520. https://doi.org/10.1200/jco.2002.20.2.514

Article  PubMed  Google Scholar